Etesevimab in combination with JS026 neutralizing SARS-CoV-2 and its variants

Wang, FZ; Li, L; Dou, Y; Shi, R; Duan, XM; Liu, HC; Zhang, J; Liu, DD; Wu, J; He, Y; Lan, J; Lu, B; Feng, H; Yan, JH

Yan, JH (通讯作者)，Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.;Feng, H (通讯作者)，Shanghai Junshi Biosci Co Ltd, Shanghai 200126, Peoples R China.;Lu, B (通讯作者)，Tsinghua Univ, Sch Pharmaceut Sci, IDG McGovern Inst Brain Res, Beijing 100084, Peoples R China.

EMERGING MICROBES & INFECTIONS, 2022; 11 (1): 548

Abstract

The neutralizing antibody is a potential therapeutic for the ongoing COVID-19 pandemic. As an antiviral agent, numerous mAbs recognize the epitopes th......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索